Archives
Showing 51 - 60 of 67 posts
https://www.coltonconsortium.org/publications/ifn-%ce%b3-producing-th1-cells-and-dysfunctional-regulatory-t-cells-contribute-to-the-pathogenesis-of-sjogrens-disease/
https://www.coltonconsortium.org/publications/defining-on-treatment-remission-in-plaque-psoriasis-a-consensus-statement-from-the-national-psoriasis-foundation/
https://www.coltonconsortium.org/publications/description-of-a-novel-splice-site-variant-in-uba1-gene-causing-vexas-syndrome/
https://www.coltonconsortium.org/publications/a-retrospective-evaluation-of-glucagon-like-peptide-1-receptor-agonists-in-systemic-lupus-erythematosus-patients/
https://www.coltonconsortium.org/publications/association-of-autoantibody-concentrations-and-trajectories-with-lupus-nephritis-histologic-features-and-treatment-response/
https://www.coltonconsortium.org/publications/blood-immunophenotyping-identifies-distinct-kidney-histopathology-and-outcomes-in-patients-with-lupus-nephritis/
https://www.coltonconsortium.org/publications/clinical-and-ultrasound-features-of-a-cohort-of-psoriasis-patients-without-musculoskeletal-symptoms-a-prospective-and-multicenter-study/
https://www.coltonconsortium.org/publications/clns1a-regulates-genome-stability-and-cell-cycle-progression-to-control-cd4-t-cell-function-and-autoimmunity/
https://www.coltonconsortium.org/publications/publication-2/
Complete
https://www.coltonconsortium.org/news/nyu-langone-study-identifies-precision-approach-to-dialing-down-harmful-t-cell-activity-in-autoimmune-disease/
A Colton-supported NYU Langone study has engineered a bispecific antibody that precisely silences harmful T cell activity — showing promise across mouse models of type 1 diabetes, hepatitis, and multiple sclerosis.
